Experimental studies in mice and studies of the virus-specific T-cell response in humans have shown that the combination of non-neutralizing antibodies with CD8+ and CD4+ T cells can provide protection against highly pathogenic influenza infection [9,30,31,32,33,34,35]. This evidence concerns the gene CD8A and influenza.